Aryzta H1 Profit Declines 15.5%, Revenue Up

Aryzta AG reported mixed results for the first half of fiscal 2025, with profit declining 15.5% to 49.1 million euros, yet revenues climbed 3% to 1.09 billion euros, driven by a strong second quarter. Despite the profit decrease, earnings per share rose 12.4% to 1.84 euros, and EBITDA marginally increased to 150.5 million euros, though the EBITDA margin compressed to 13.9%. The specialty bakery product manufacturer reaffirmed its full-year 2025 outlook for low to mid-single digit organic growth, EBITDA margin expansion, and higher EPS growth, signaling management confidence despite current profit headwinds.

Analysis

Aryzta AG's financial results for the first half of fiscal 2025 present a mixed operational picture, characterized by top-line growth offset by margin pressure. Revenue increased by 3% to 1.09 billion euros, a positive signal attributed to a strong second quarter performance. However, this growth did not translate to the bottom line, as net profit declined by 15.5% to 49.1 million euros. The core issue appears to be profitability, with the EBITDA margin contracting to 13.9% from 14.2% year-over-year, and absolute EBITDA remaining nearly flat at 150.5 million euros. A notable divergence is the 12.4% increase in earnings per share to 1.84 euros, which, when contrasted with the fall in net profit, strongly suggests a significant reduction in the number of outstanding shares. Despite the H1 margin compression, management reaffirmed its full-year 2025 guidance for low to mid-single digit organic growth and, critically, EBITDA margin expansion, signaling confidence that cost pressures will be managed more effectively in the second half of the year.

Key Decisions for Investors

• Investors should closely monitor the company's ability to deliver on its guidance for full-year EBITDA margin expansion, as the 30 basis point contraction in the first half places significant performance pressure on the second half.
• Consider that the 12.4% EPS growth was achieved despite a 15.5% decline in net profit, indicating it was primarily driven by a reduction in share count rather than improved operational profitability.
• A neutral stance may be warranted until there is clear evidence of the margin recovery and organic growth projected in the company's reaffirmed outlook, as the investment thesis now hinges on a strong second-half performance.